BridgeBio
About BridgeBio
BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases.
Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible.
BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
Company Details
200M-500M
Biotechnology Research
201-500 employees
Public Company
Palo Alto, California
United States
Frequently Asked Questions about
What is BridgeBio's industry?
BridgeBio operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does BridgeBio have?
BridgeBio has approximately 201-500 employees employees.
Where is BridgeBio's based?
BridgeBio is based in Palo Alto, California, United States.
Is BridgeBio publicly listed?
Yes. BridgeBio is a publicly traded company.
How can I contact BridgeBio's investor relations team?
You can reach BridgeBio’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.